It is a pharma private limited company based in U T, Chandigarh, India, established in 2003.
2003 | U T, Chandigarh, India | ActiveKenn Pharmaceuticals Private Limited, a active private limited company, was established on 26 September 2003 in U T, Chandigarh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24200CH2003PTC026409. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.35 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Poonam Narad (Whole-Time Director), Mihul (Director). Past directors included Rakesh Kant Narad, Rupica Narad, Ashwani Sharma. It holds ₹3.35 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sco 846 1St Floornac Manimajra Chandigarh, U T, Chandigarh, 160101.
U24200CH2003PTC026409
026409
26 September 2003
₹0.35 M
₹0.10 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Kenn Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Poonam Narad | Whole-Time Director | 13 Jan 2017 | Current |
| Mihul | Director | 16 Jun 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Dec 2014 | Past |
| Pramod Abcsdd | Director | 30 Mar 2022 | Past |
| Pramod Abcsdd | Director | 06 Dec 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kenn Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 12.85% increase. The company also saw a slight decrease in profitability, with a 0.45% decrease in profit. The company's net worth moved up by a moderate rise of 0.57%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Kenn Pharmaceuticals had a promoter holding of 10.00% and a public holding of 90.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,350,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jun 2020 | Others | ₹0.55 M | Open |
| 16 Oct 2012 | Corporation Bank | ₹2.80 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Kenn Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kenn Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kenn Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kenn Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Kenn Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 0.55 M with Charge ID 100343052 was registered on 08 Jun 2020. was completed.
A charge with Others of Rs. 0.55 M registered on 08 Jun 2020 with Charge ID 100343052 was modified on 08 Jun 2020. was recorded as a recent event.
Progress on Poonam Narad was appointed as a Whole-time director was appointed as a Whole-time director on 13 Jan 2017 & has been associated with this company since 8 years 11 months . was documented.
Progress on Mihul was appointed as a Director was appointed as a Director on 16 Jun 2014 & has been associated with this company since 11 years 6 months . was documented.
The CIN of Kenn Pharmaceuticals Private Limited is U24200CH2003PTC026409.
Kenn Pharmaceuticals Private Limited is headquartered at Sco 846 1St Floornac Manimajra Chandigarh, U T, Chandigarh, 160101.
Kenn Pharmaceuticals Private Limited was incorporated on 26 September 2003.
The current directors of Kenn Pharmaceuticals Private Limited are
The primary industry of Kenn Pharmaceuticals Private Limited is Pharma.
Kenn Pharmaceuticals Private Limited is unlisted.
The authorized capital of Kenn Pharmaceuticals Private Limited is ₹0.35 M, and the paid-up capital is ₹0.10 M.
The compliance status of Kenn Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX